Scroll back to the halcyon days of 2020, when the Internet was overflowing with self-love sermons, plus-size runway shows, and pastel infographics reminding us to “embrace every curve.” Now ...

Novo Nordisk NVO has experienced remarkable growth in recent years, largely fueled by the commercial success of its ...

MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...

The Semaglutide peptide has emerged as a compelling subject in biochemical and physiological research due to its potential ...

A new study found that Ozempic's main ingredient may treat people with type 1 diabetes, control blood sugar, and lose weight.

VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.

Good Morning Washington recently sat down with Dr. Patel, a double board-certified physician from Physicians Premiere Weight ...

Wegovy (semaglutide) will no longer be available through Hims & Hers Health, as Novo Nordisk has ended its short-lived partnership.

Now, after gaining all that weight back due to not being able to continually and severely restrict my diet, I am using semaglutide. If and when it is as successful, I hope that somebody notices and ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

In summary, semaglutide is helpful for people with type 2 diabetes. It can lower blood sugar and help with weight loss. The ...

After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...